BVS Bioventus

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market opens on Tuesday, May 7, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.

To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.

A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at . The webcast will be archived at the same site and available for replay until May 6, 2025.

About Bioventus

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit and follow the Company on and . Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:

Dave Crawford

919-474-6787



EN
29/04/2024

Underlying

BVSBioventus

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bioventus

 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus Reports First Quarter Financial Results

Bioventus Reports First Quarter Financial Results Raises Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic PrioritiesAccelerated First Quarter Revenue Growth by 8.7%, Organic Growth* by 15.3%Gross Margin Expanded 620 bps and Adjusted Gross Margin* 190 bps DURHAM, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the three months ended March 30, 2024. “We are pleased with the strong start to the year...

May 7, 2024 1 EN
 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Result...

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024 DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2024 before the market opens on Tuesday, May 7, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call. A liv...

April 29, 2024 1 EN
 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Result...

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the global medical device industryProvides full-year 2024 financial guidance reflecting enhanced revenue growth and improved execution DURHAM, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced fourth quarter ...

March 12, 2024 1 EN
 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Resul...

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024 DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- a global leader in innovations for active healing, today announced that it will report financial results for the fourth quarter of fiscal year 2024 before the market opens on Tuesday, March 12, 2024. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update. To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call...

March 4, 2024 1 EN
 PRESS RELEASE
Free
BVS BIOVENTUS

Bioventus Enters into an Amendment with its Credit Agreement Lenders t...

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- a global leader in innovations for active healing, today announced that it has entered into an Amendment No. 5 (the “Amendment”) to the Credit and Guaranty Agreement, between the Company, Wells Fargo Bank, National Association as Administrative Agent and Collateral Agent, and the Lenders from time to time party thereto, dated as of December 6, 2019 and as amended on August 29, 2021, October 29, 2021, July 11, 2022 and March ...

January 18, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch